NX
NEXGEL, Inc.
NXGL · NASDAQ
$0.27 +5.81% (+$0.01)
1M -19.45%
Market Cap $2.12M
P/E Ratio -
Div. Yield -
ROE 133.10%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.43x
P/S 0.18x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 16.42%
Rev. growth 77.33%
FCF growth N/A
Profitability
14 /100
Weak Net margin 51.26%
Op. margin 44.77%
FCF margin 27.10%
Quality
6 /100
Poor ROE 133.10%
ROA 23.39%
Asset turnover 0.46x
Debt
17 /100
High Current ratio 0.43x
Int. coverage -1.73x
Debt/Equity 1.49x
Stability
56 /100
Moderate Rev. volatility 43.55%
EPS volatility 11.74%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NXGL
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Brian J. Kieser
Employees
19
Headquarters
Langhorne
Evenimente viitoare
10 NOV.
Earnings
Upcoming earnings report